Refining Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: T Stands for Trastuzumab, Tumor Size, and Treatment Strategy
Burstein HJ, Winer EP. Refining Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: T Stands for Trastuzumab, Tumor Size, and Treatment Strategy. Journal Of Clinical Oncology 2009, 27: 5671-5673. PMID: 19884535, DOI: 10.1200/jco.2009.24.2222.Peer-Reviewed Original Research